HIGHLIGHTS
- who: Wieke C. H. Visser from the Italy Italy have published the article: Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer, in the Journal: (JOURNAL) of 11/05/2022
- what: The aim of this study is to obtain insight into the clinical use of the SelectMDx test in daily practice based on 5157 samples from ten European countries.
- how: Next the ratio positive and negative SelectMDx test results were compared between each country and the validation cohort. During the development and optimization of biomarker tests studies are conducted including . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.